Pubdate: Mon, 14 May 2001 Source: Associated Press (Wire) Copyright: 2001 Associated Press Details: http://www.mapinc.org/media/27 Author: Anjetta McQueen, Associated Press Writer Bookmark: http://www.mapinc.org/find?186 (Oxycontin) GROUP PLEDGES TO FIGHT OXYCONTIN WASHINGTON (AP) - State law enforcement chiefs pledged Monday to fight the growing abuse of OxyContin, a painkiller primarily prescribed for cancer patients. A national task force launched by the officials will study current programs, including a computer database that helps spot potential abusers. "This drug can be the angel of life when used appropriately," said Mark Earley, attorney general of Virginia, where OxyContin abuse has led to at least 32 overdose deaths. "When used illegally it can be an angel of death." OxyContin, a synthetic morphine hailed as a miracle drug for patients suffering severe pain, has become a popular illicit drug in some parts of the country. Users grind the pills, snort the powder or inject a mixture of powder and water, hoping for an effect similar to that of heroin, officials said. Many users seek extra portions from doctors and pharmacists, but others simply break into drug stores or steal doctors' prescription pads to forge prescriptions. Maryland Attorney General Joseph Curran Jr. said the abuse of the prescription drug is becoming a national problem, spreading from western Virginia and other parts of the Appalachian Mountains. More than 120 overdose deaths nationwide have been linked to OxyContin. Earley said officials will study several state efforts to fight prescription drug abuse and make recommendations to their respective legislatures. A potential national model includes a Kentucky system in which doctors, pharmacists, police, prosecutors and others can use the database to figure out whether a person is filling multiple prescriptions for the same drug at different locations, which might indicate the person is overusing or illegally selling the drug. Industry and federal officials are taking action as well, the attorneys general said. Last week, Purdue Pharma, the drug's Connecticut-based maker, suspended shipments of large-dose tablets. Also this month, the Drug Enforcement Administration said it would target aggressively doctors and pharmacists who over-prescribe the medication. - --- MAP posted-by: Terry Liittschwager